Interim Chief Executive Officer: Priya Mande

Priya Mande is a founding member of PsiOxus with 30 years of experience in the pharmaceutical and biotech sector.  She joined the PsiOxus Board of Directors in 2016.   Since 2010, she has overseen the growth of PsiOxus in the UK and USA holding responsibility for corporate development, project management, clinical, QA, finance, legal and operations as Chief Operating Officer.  In 2020, she was seconded to the prestigious UK Vaccine Taskforce in the fight against Covid-19. Priya has previously worked at GlaxoSmithKline where she was R&D Strategy Director supporting the R&D Executive.  She also held roles across research, development, finance and business strategy whilst at GSK.  At PowderMed, she was responsible for delivery of the vaccine portfolio which sold to Pfizer for over US$300 million in 2006.  Priya subsequently became the Vaccine Research Project Leader for Influenza at Pfizer.  Priya studied Applied Biochemistry at Brunel University London, received her MBA with distinction from the London Business School and was awarded Chartered Director status by the UK Institute of Directors in 2020.

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image